Double-Dose eye injections: how much drug gets into your bloodstream?
NCT ID NCT06591598
Summary
This study aimed to understand how much of a high-dose eye medication gets into the bloodstream when injected into both eyes. It involved 51 adults with diabetic macular edema or 'wet' age-related macular degeneration. Researchers measured the highest drug concentration in participants' blood after they received multiple injections in both eyes to ensure the treatment is safe at this higher dose.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOVASCULAR AGE-RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Axon Clinical, s.r.o.
Prague, 150 00, Czechia
-
Budapest Retina Associates
Budapest, 1133, Hungary
-
Debreceni Egyetem Klinikai Kozpont
Debrecen, 4032, Hungary
-
Fakultna nemocnica s poliklinikou Zilina
Žilina, 012 07, Slovakia
-
Fakultní nemocnice Královské Vinohrady - Urologická klinikay
Prague, 10034, Czechia
-
Univerzitna nemocnica Bratislava, Nem. Sv. Cyrila a Metoda
Bratislava, 851 07, Slovakia
Conditions
Explore the condition pages connected to this study.